sacrosidase
Sign in to saveAlso known as Sucraid
Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme. It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sacrosidase assists in the breakdown of sugar/sucrose into simpler forms and is useful for the relief of gastrointestinal symptoms that are associated with CSID.
Medication
- Generic name
- Sacrosidase
- Brand names
- Sucraid
- Drug class
- Sucrose-specific Enzyme, Enzymes
- Active ingredients
- sacrosidase
- Route
- Oral
- Dosage form
- Oral Solution
- Type
- Human Prescription Drug
- Manufacturer
- QOL Medical, LLC
Indications: INDICATIONS AND USAGE Sucraid ® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older. (per FDA label)
Clinical Trials
4 registered- PHASE4WITHDRAWNA Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase DeficiencyQOL Medical, LLC · NCT02784067
- COMPLETEDAdult Pilot Study for Reference Ranges and Optimal Cut-offs for the Sucrose Challenge Test and Sucrose Breath TestQOL Medical, LLC · NCT05045495
- PHASE4TERMINATED7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase LevelsQOL Medical, LLC · NCT05480761
- PHASE2COMPLETEDEffects of Sacrosidase and Placebo in Subjects With Fructan IntoleranceQOL Medical, LLC · NCT05703009
Wikidata facts
- Instance of
- medication
Show 1 more fact
- NCI Thesaurus ID
- C66525
Sources (1)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- References
- External links
Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme. It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sacrosidase assists in the breakdown of sugar/sucrose into simpler forms and is useful for the relief of gastrointestinal symptoms that are associated with CSID.
==References==
Excerpted from Wikipedia’s “sacrosidase” article, available under the CC BY-SA 4.0 licence.